BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17616640)

  • 21. 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics.
    Eisenmann KM; Dykema KJ; Matheson SF; Kent NF; DeWard AD; West RA; Tibes R; Furge KA; Alberts AS
    Oncogene; 2009 Oct; 28(39):3429-41. PubMed ID: 19597464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients.
    Pellagatti A; Jädersten M; Forsblom AM; Cattan H; Christensson B; Emanuelsson EK; Merup M; Nilsson L; Samuelsson J; Sander B; Wainscoat JS; Boultwood J; Hellström-Lindberg E
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11406-11. PubMed ID: 17576924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary study on origination of bone marrow abnormal clones in patients with myelodysplastic syndrome].
    Zhang QX; Li X; He Q; Wu LY; Xu F; Zhang Z
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):930-4. PubMed ID: 21867617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine.
    Giachelia M; D'Alò F; Fabiani E; Saulnier N; Di Ruscio A; Guidi F; Hohaus S; Voso MT; Leone G
    Leuk Res; 2011 Apr; 35(4):465-71. PubMed ID: 20869114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative gene expression in hematopoietic progenitor cells derived from embryonic stem cells.
    Lu SJ; Li F; Vida L; Honig GR
    Exp Hematol; 2002 Jan; 30(1):58-66. PubMed ID: 11823038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of molecular targets on the surface of CD34+/CD38-- stem cells in various myeloid malignancies.
    Florian S; Sonneck K; Hauswirth AW; Krauth MT; Schernthaner GH; Sperr WR; Valent P
    Leuk Lymphoma; 2006 Feb; 47(2):207-22. PubMed ID: 16321850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expressions of CD96 and CD123 in Bone Marrow Cells of Patients with Myelodysplastic Syndromes.
    Zhang W; Shao Z; Fu R; Wang H; Li L; Liu H
    Clin Lab; 2015; 61(10):1429-34. PubMed ID: 26642704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears.
    Bigoni R; Cuneo A; Milani R; Cavazzini F; Bardi A; Roberti MG; Agostini P; della Porta M; Specchia G; Rigolin GM; Castoldi G
    Haematologica; 2001 Apr; 86(4):375-81. PubMed ID: 11325642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDS: a stem cell disorder--but what exactly is wrong with the primitive hematopoietic cells in this disease?
    Nimer SD
    Hematology Am Soc Hematol Educ Program; 2008; ():43-51. PubMed ID: 19074057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis.
    Rizo A; Olthof S; Han L; Vellenga E; de Haan G; Schuringa JJ
    Blood; 2009 Aug; 114(8):1498-505. PubMed ID: 19556423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptome analysis of CD34+ cells from myelodysplastic syndrome patients.
    Ou R; Huang J; Shen H; Liu Z; Zhu Y; Zhong Q; Zheng L; Yao M; She Y; Zhou S; Chen R; Li C; Zhang Q; Liu S
    Leuk Res; 2017 Nov; 62():40-50. PubMed ID: 28982058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome.
    Bereshchenko O; Lo Re O; Nikulenkov F; Flamini S; Kotaskova J; Mazza T; Le Pannérer MM; Buschbeck M; Giallongo C; Palumbo G; Li Volti G; Pazienza V; Cervinek L; Riccardi C; Krejci L; Pospisilova S; Stewart AF; Vinciguerra M
    Clin Epigenetics; 2019 Aug; 11(1):121. PubMed ID: 31439048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations.
    Will B; Zhou L; Vogler TO; Ben-Neriah S; Schinke C; Tamari R; Yu Y; Bhagat TD; Bhattacharyya S; Barreyro L; Heuck C; Mo Y; Parekh S; McMahon C; Pellagatti A; Boultwood J; Montagna C; Silverman L; Maciejewski J; Greally JM; Ye BH; List AF; Steidl C; Steidl U; Verma A
    Blood; 2012 Sep; 120(10):2076-86. PubMed ID: 22753872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Detection of -5/5q- chromosome abnormality in myelodysplastic syndromes by interphase fluorescence in situ hybridization].
    Shen Y; Xue Y; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):517-9. PubMed ID: 11769675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1.
    Oguro H; Yuan J; Ichikawa H; Ikawa T; Yamazaki S; Kawamoto H; Nakauchi H; Iwama A
    Cell Stem Cell; 2010 Mar; 6(3):279-86. PubMed ID: 20207230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.
    Woll PS; Kjällquist U; Chowdhury O; Doolittle H; Wedge DC; Thongjuea S; Erlandsson R; Ngara M; Anderson K; Deng Q; Mead AJ; Stenson L; Giustacchini A; Duarte S; Giannoulatou E; Taylor S; Karimi M; Scharenberg C; Mortera-Blanco T; Macaulay IC; Clark SA; Dybedal I; Josefsen D; Fenaux P; Hokland P; Holm MS; Cazzola M; Malcovati L; Tauro S; Bowen D; Boultwood J; Pellagatti A; Pimanda JE; Unnikrishnan A; Vyas P; Göhring G; Schlegelberger B; Tobiasson M; Kvalheim G; Constantinescu SN; Nerlov C; Nilsson L; Campbell PJ; Sandberg R; Papaemmanuil E; Hellström-Lindberg E; Linnarsson S; Jacobsen SE
    Cancer Cell; 2014 Jun; 25(6):794-808. PubMed ID: 24835589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RUNX1/AML1 mutant collaborates with BMI1 overexpression in the development of human and murine myelodysplastic syndromes.
    Harada Y; Inoue D; Ding Y; Imagawa J; Doki N; Matsui H; Yahata T; Matsushita H; Ando K; Sashida G; Iwama A; Kitamura T; Harada H
    Blood; 2013 Apr; 121(17):3434-46. PubMed ID: 23471304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular cytogenetic delineation of the critical deleted region in the 5q- syndrome.
    Jaju RJ; Boultwood J; Oliver FJ; Kostrzewa M; Fidler C; Parker N; McPherson JD; Morris SW; Müller U; Wainscoat JS; Kearney L
    Genes Chromosomes Cancer; 1998 Jul; 22(3):251-6. PubMed ID: 9624537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosomal instability and telomere shortening in long-term culture of hematopoietic stem cells: insights from a cell culture model of RPS14 haploinsufficiency.
    Thomay K; Schienke A; Vajen B; Modlich U; Schambach A; Hofmann W; Schlegelberger B; Göhring G
    Cytogenet Genome Res; 2014; 142(1):14-20. PubMed ID: 24192547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
    Pellagatti A; Cazzola M; Giagounidis AA; Malcovati L; Porta MG; Killick S; Campbell LJ; Wang L; Langford CF; Fidler C; Oscier D; Aul C; Wainscoat JS; Boultwood J
    Blood; 2006 Jul; 108(1):337-45. PubMed ID: 16527891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.